Randomised, double-blind, multicentre clinical trial to evaluate the efficacy and safety of topical metformin in adjuvant to daylight photodynamic therapy in actinic keratoses.
interventional
N/A
1 country
3
To determine the efficacy and safety of topical metformin as an adjuvant to daylight photodynamic therapy (dPDT) with methyl aminolevulinate (MAL) in the treatment of actinic keratoses and the cancerisation field.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 28, 2025
Actual (reported)Patients will receive treatment for 12 weeks and will be observed for 36 weeks after completion of treatment to assess clinical efficacy and adverse effects.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Hospital Universitario Fundacion Alcorcon
Alcorcon, 28922, Spain
Hospital General Universitario De Ciudad Real
Ciudad Real, 13005, Spain
Hospital Universitario Miguel Servet
Zaragoza, 50009, Spain
Clinical Investigation Unit
First Submitted
January 28, 2025
Download the complete CTIS (EMA) record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: European Medicines Agency (EMA), Clinical Trials Information System (CTIS). Original record and public documents are available on CTIS.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Contact the study team to confirm eligibility.